Consensus Genovis AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:37 2024-05-24 am EDT			5-day change	1st Jan Change
33.9 ^SEK	-4.10%		+0.30%	-34.81%

May. 15	Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 14	Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	CI

9.4LFCzmpue_PAtGCMUTez0NUiVhV28evs6tGb0yhQr4o.rJwIkS4NGJry5zX5HQXeqb9jY0JEiL7foZXxqWEqmfik6XCZAFpJko7jBw~389971423c88af0e6a7701bd52734edb

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

33.9 SEK

Average target price

51.5 SEK

Spread / Average Target

+51.92%

High Price Target

65 SEK

Spread / Highest target

+91.74%

Low Price Target

38 SEK

Spread / Lowest Target

+12.09%

Trading Rating

Investor Rating

ESG Refinitiv

D+